Suneris adds new staff; Kindred reports Q2 results; Patterson promotes Korsh;

> Suneris hired four new members whose positions will focus on research, regulatory affairs, operations and sales. Announcement

> Kindred Biosciences ($KIN) reported second-quarter losses slightly narrower than year before. Announcement

> Patterson ($PDCO) promoted Les Korsh to vice president, general counsel and secretary. Announcement

> Aratana Thereapeutics ($PETX) elected Wendy Yarno as chairman of its board of directors, replacing Jay Lichter. Announcement

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…